APA (7th ed.) Citation

MH, C., HY, W., WC, K., CC, C., MY, J., YT, H., . . . JY, C. (2025). Cardio-kidney outcomes for combined versus monotherapy with finerenone or SGLT2 inhibitors in patients with CKD. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 40(10), 1897. https://doi.org/10.1093/ndt/gfaf064

Chicago Style (17th ed.) Citation

MH, Chuang, Wang HY, Kan WC, Chien CC, Jiang MY, Huang YT, Wu VC, and Chen JY. "Cardio-kidney Outcomes for Combined Versus Monotherapy with Finerenone or SGLT2 Inhibitors in Patients with CKD." Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association 40, no. 10 (2025): 1897. https://doi.org/10.1093/ndt/gfaf064.

MLA (9th ed.) Citation

MH, Chuang, et al. "Cardio-kidney Outcomes for Combined Versus Monotherapy with Finerenone or SGLT2 Inhibitors in Patients with CKD." Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association, vol. 40, no. 10, 2025, p. 1897, https://doi.org/10.1093/ndt/gfaf064.